The estimated lifetime risk of breast cancer for CHEK2 mutation carriers (mostly c.1100delC) differs according to family cancer history and ranges from 20 to 40% in women without and with a positive family breast cancer history, respectively [150]. The gene discussed is CHEK2; the disease is breast carcinoma.